Effect of Two Different Remifentanil Doses On Stress Response And Awareness During Modified Rapid Sequence Induction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201601001412346

Enrollment

Registered

2016-01-06

Start date

2014-02-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Surgery

Interventions

dexmetidomedine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA physical status I and II , Age group18-60 years old Body mass index (BMI) < 30

Exclusion criteria

Exclusion criteria: Patients with hypersensitivity to Remifentanil , Propofol or Rocuronium , severe renal or hepatic disease , severe cardiac dysfunction , hypertension , muscle disease and expected difficult intubation

Design outcomes

Primary

Measure	Time frame
increase in heart rate, blood pressure	—

Countries

Egypt

Contacts

Public Contacthazem a.wahab

lecturer of anesthesia

hazemwahab@yahoo.com01153517862

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026